Works matching AU Collins, Jerry M.

Results: 31

Radiosynthesis of [11C]paclitaxel.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2002, v. 45, n. 6, p. 471, doi. 10.1002/jlcr.571

By:

Ravert, Hayden T.;
Klecker, Raymond W.;
Collins, Jerry M.;
Mathews, William B.;
Pomper, Martin G.;
Wahl, Richard L.;
Dannals, Robert F.

Publication type:

Article

Biodistribution and Radiation Dosimetry Estimates of 1-(2'-Deoxy-2'-18F-Fluoro-1-β-D-Arabinofuranosyl)- 5-Bromouracil: PET Imaging Studies in Dogs.

Published in:

Journal of Nuclear Medicine, 2005, v. 46, n. 11, p. 1916

By:

Nimmagadda, Sridhar;
Mangner, Thomas J.;
Sun, Haihao;
Klecker Jr., Raymond W.;
Muzik, Otto;
Lawhorn-Crews, Jawana M.;
Douglas, Kirk A.;
Collins, Jerry M.;
Shields, Anthony F.

Publication type:

Article

Imaging DNA Synthesis In Vivo with 18F-FMAU and PET.

Published in:

Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 292

By:

Sun, Haihao;
Mangner, Thomas J.;
Collins, Jerry M.;
Muzik, Otto;
Douglas, Kirk;
Shields, Anthony F.

Publication type:

Article

A case report of typhlitis during novel use of ropidoxuridine–capecitabine–radiotherapy for treatment-naïve rectal cancer.

Published in:

2023

By:

Kunos, Charles A.;
Piekarz, Richard;
Collins, Jerry M.;
Kinsella, Timothy J.

Publication type:

Case Study

Metabolic profile of XK469 (2( R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 351, doi. 10.1007/s00280-004-0962-3

By:

Anderson, Lawrence W.;
Collins, Jerry M.;
Klecker, Raymond W.;
Katki, Aspandiar G.;
Parchment, Ralph E.;
Boinpally, Ramesh R.;
LoRusso, Patricia M.;
Ivy, S. Percy

Publication type:

Article

Thymidine phosphorylase as a target for imaging and therapy with thymine analogs.

Published in:

2001

By:

Klecker Jr., Raymond W.;
Collins, Jerry M.;
Klecker, R W Jr;
Collins, J M

Publication type:

journal article

Pharmacokinetic Aspects of Arterial Fluoropyrimidine Delivery.

Published in:

Annals of the New York Academy of Sciences, 1991, v. 618, n. 1, p. 345, doi. 10.1111/j.1749-6632.1991.tb27254.x

By:

COLLINS, JERRY M.

Publication type:

Article

A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention.

Published in:

2007

By:

Shields, Anthony F.;
Briston, David A.;
Chandupatla, Samatha;
Douglas, Kirk A.;
Lawhorn-Crews, Jawana;
Collins, Jerry M.;
Mangner, Thomas J.;
Heilbrun, Lance K.;
Muzik, Otto

Publication type:

Correction Notice

A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 11, p. 1269, doi. 10.1007/s00259-005-1813-0

By:

Shields, Anthony;
Briston, David;
Chandupatla, Samatha;
Douglas, Kirk A.;
Lawhorn-Crews, Jawana;
Collins, Jerry M.;
Mangner, Thomas J.;
Heilbrun, Lance K.;
Muzik, Otto

Publication type:

Article

In Vitro Human Tissue Models in Risk Assessment: Report of a Consensus-Building Workshop.

Published in:

Toxicological Sciences, 2001, v. 59, n. 1, p. 17, doi. 10.1093/toxsci/59.1.17

By:

MacGregor, James T.;
Collins, Jerry M.;
Sugiyama, Yuichi;
Tyson, Charles A.;
Dean, Jack;
Smith, Lewis;
Andersen, Melvin;
Curren, Rodger D.;
Houston, J. Brian;
Kadlubar, Fred F.;
Kedderis, Gregory L.;
Krishnan, Kannan;
Li, Albert P.;
Parchment, Ralph E.;
Thummel, Kenneth;
Tomaszewski, Joseph E.;
Ulrich, Roger;
Vickers, Alison E. M.;
Wrighton, Steven A.

Publication type:

Article

Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development.

Published in:

JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 16, p. 1321

By:

Collins, Jerry M.;
Grieshaber, Charles K.;
Chabner, Bruce A.

Publication type:

Article

Pharmacology and Clinical Toxicity of 4′-Iodo-4′-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials.

Published in:

JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 6, p. 469

By:

Gianni, Luca;
Viganò, Lucia;
Surbone, Antonella;
Ballinari, Dario;
Casali, Paolo;
Tarella, Corrado;
Collins, Jerry M.;
Bonadonna, Gianni

Publication type:

Article

Enhancement of fluorinated Pyrimidine-Induced Cytotoxicity by Leucovorin in Human Colorectal Carcinoma Cell Lines.

Published in:

JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 19, p. 1560

By:

Park, Jae-Gahb;
Collins, Jerry M.;
Gazdar, Adi F.;
Allegra, Carmen J.;
Steinberg, Seth M.;
Greene, Raymond F.;
Kramer, Barnett S.

Publication type:

Article

Pharmacology and Drug Development.

Published in:

JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 11, p. 790

By:

Collins, Jerry M.

Publication type:

Article

Dextran sulfate is poorly absorbed after oral administration.

Published in:

1989

By:

Lorentsen, Kevin J.;
Hendrix, Craig W.;
Collins, Jerry M.;
Kornhauser, David M.;
Petty, Brent G.;
Klecker, Raymond W.;
Flexner, Charles;
Eckel, Robert H.;
Lietman, Paul S.;
Lorentsen, K J;
Hendrix, C W;
Collins, J M;
Kornhauser, D M;
Petty, B G;
Klecker, R W;
Flexner, C;
Eckel, R H;
Lietman, P S

Publication type:

journal article

Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT.

Published in:

Cancer Imaging, 2016, v. 16, p. 1, doi. 10.1186/s40644-016-0092-2

By:

McHugh, Christopher I.;
Lawhorn-Crews, Jawana M.;
Modi, Dipenkumar;
Douglas, Kirk A.;
Jones, Steven K.;
Mangner, Thomas J.;
Collins, Jerry M.;
Shields, Anthony F.

Publication type:

Article

Metabolism by N-Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition.

Published in:

Journal of Clinical Pharmacology, 2004, v. 44, n. 12, p. 1405, doi. 10.1177/0091270004270224

By:

Cantilena, Louis R.;
Katki, Aspandiar G.;
Klecker, Raymond W.;
Collins, Jerry M.

Publication type:

Article

Evaluation of Highly Bound Drugs: Interspecies, Intersubject, and Related Comparisons.

Published in:

Journal of Clinical Pharmacology, 2002, v. 42, n. 9, p. 971, doi. 10.1177/009127000204200903

By:

Collins, Jerry M.;
Klecker, Raymond W.

Publication type:

Article

Pharmacokinetics of 2',3'-Dideoxycytidine in Patients with AIDS and Related Disorders.

Published in:

1988

By:

Klecker, Raymond W.;
Collins, Jerry M.;
Yarchoan, Robert C.;
Thomas, Rose;
McAtee, Nanette;
Broder, Samuel;
Myers, Charles E.

Publication type:

Other

Clinical Pharmacokinetics of Suramin in Patients With HTLV-III/LAV Infection.

Published in:

1986

By:

PhD, Jerry M. Collins;
Klecker, Raymond W.;
Yarchoan, Robert;
Lane, H. Clifford;
Fauci, Anthony S.;
Redfield, Robert R.;
Broder, Samuel;
Myers, Charles E.

Publication type:

Other

Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone*.

Published in:

Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 6, p. 597, doi. 10.1016/S0009-9236(98)90050-9

By:

Trapnell, Carol Braun;
Donahue, Stephen R.;
Collins, Jerry M.;
Flockhart, David A.;
Thacker, David;
Abernethy, Darrell R.

Publication type:

Article

Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium.

Published in:

Neuro-Oncology, 2004, v. 6, n. 1, p. 65, doi. 10.1215/S1152851703000103

By:

Benjamin, Ramsis K.;
Hochberg, Fred H.;
Fox, Elizabeth;
Bungay, Peter M.;
Elmquist, William F.;
Stewart, Clinton F.;
Gallo, James M.;
Collins, Jerry M.;
Pelletier, Robert P.;
de Groot, John F.;
Hickner, Robert C.;
Cavus, Idil;
Grossman, Stuart A.;
Colvin, O. Michael

Publication type:

Article

Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver.

Published in:

Clinical Pharmacology & Therapeutics, 1988, v. 44, n. 4, p. 369, doi. 10.1038/clpt.1988.166

By:

Speth, Paul A J;
Kinsella, Timothy J;
Chang, Alfred E;
Klecker, Raymond W;
Belanger, Karl;
Collins, Jerry M

Publication type:

Article

The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.

Published in:

Clinical Pharmacology & Therapeutics, 1987, v. 41, n. 4, p. 384, doi. 10.1038/clpt.1987.45

By:

Balis, Frank M;
Holcenberg, John S;
Zimm, Solomon;
Tubergen, David;
Collins, Jerry M;
Murphy, Robert F;
Gilchrist, Gerald S;
Hammond, Denman;
Poplack, David G

Publication type:

Article

Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

Published in:

Clinical Pharmacology & Therapeutics, 1987, v. 41, n. 4, p. 407, doi. 10.1038/clpt.1987.49

By:

Klecker, Raymond W;
Collins, Jerry M;
Yarchoan, Robert;
Thomas, Rose;
Jenkins, Jean F;
Broder, Samuel;
Myers, Charles E

Publication type:

Article

Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation.

Published in:

Clinical Pharmacology & Therapeutics, 1985, v. 38, n. 1, p. 45, doi. 10.1038/clpt.1985.132

By:

Klecker, Raymond W;
Jenkins, Jean F;
Kinsella, Timothy J;
Fine, Robert L;
Strong, John M;
Collins, Jerry M

Publication type:

Article

Cytosine arabinoside cerebrospinal fluid kinetics.

Published in:

Clinical Pharmacology & Therapeutics, 1984, v. 35, n. 6, p. 826, doi. 10.1038/clpt.1984.120

By:

Zimm, Solomon;
Collins, Jerry M;
Miser, James;
Chatterji, Dulal;
Poplack, David G

Publication type:

Article

Inhibition of first-pass metabolism in cancer chemotherapy: Interaction of 6-mercaptopurine and allopurinol.

Published in:

Clinical Pharmacology & Therapeutics, 1983, v. 34, n. 6, p. 810, doi. 10.1038/clpt.1983.254

By:

Zimm, Solomon;
Collins, Jerry M;
O'Neill, Dondra;
Chabner, Bruce A;
Poplack, David G

Publication type:

Article

Test dose for predicting high-dose methotrexate infusions.

Published in:

Clinical Pharmacology & Therapeutics, 1983, v. 33, n. 1, p. 44, doi. 10.1038/clpt.1983.6

By:

Kerr, Ian G;
Jolivet, Jacques;
Collins, Jerry M;
Drake, James C;
Chabner, Bruce A

Publication type:

Article

Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.

Published in:

Clinical Pharmacology & Therapeutics, 1982, v. 31, n. 5, p. 650, doi. 10.1038/clpt.1982.90

By:

Bachur, Nicholas R;
Collins, Jerry M;
Kelley, James A;
Van Echo, David A;
Kaplan, Richard S;
Whitacre, Margaret

Publication type:

Article

Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routes.

Published in:

Clinical Pharmacology & Therapeutics, 1980, v. 28, n. 2, p. 235, doi. 10.1038/clpt.1980.156

By:

Collins, Jerry M;
Dedrick, Robert L;
King, Franklin G;
Speyer, James L;
Myers, Charles E

Publication type:

Article

Works matching AU Collins, Jerry M.

Radiosynthesis of [<sup>11</sup>C]paclitaxel.

Biodistribution and Radiation Dosimetry Estimates of 1-(2'-Deoxy-2'-<sup>18</sup>F-Fluoro-1-β-D-Arabinofuranosyl)- 5-Bromouracil: PET Imaging Studies in Dogs.

Imaging DNA Synthesis In Vivo with <sup>18</sup>F-FMAU and PET.

A case report of typhlitis during novel use of ropidoxuridine–capecitabine–radiotherapy for treatment-naïve rectal cancer.

Metabolic profile of XK469 (2( R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions.

Thymidine phosphorylase as a target for imaging and therapy with thymine analogs.

Pharmacokinetic Aspects of Arterial Fluoropyrimidine Delivery.

A simplified analysis of [<sup>18</sup>F]3′-deoxy-3′-fluorothymidine metabolism and retention.

A simplified analysis of [<sup>18</sup>F]3′-deoxy-3′-fluorothymidine metabolism and retention.

In Vitro Human Tissue Models in Risk Assessment: Report of a Consensus-Building Workshop.

Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development.

Pharmacology and Clinical Toxicity of 4′-Iodo-4′-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials.

Enhancement of fluorinated Pyrimidine-Induced Cytotoxicity by Leucovorin in Human Colorectal Carcinoma Cell Lines.

Pharmacology and Drug Development.

Dextran sulfate is poorly absorbed after oral administration.

Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: <sup>18</sup>F-FAU, <sup>18</sup>F-FMAU, and <sup>18</sup>F-FLT.

Metabolism by N-Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition.

Evaluation of Highly Bound Drugs: Interspecies, Intersubject, and Related Comparisons.

Pharmacokinetics of 2',3'-Dideoxycytidine in Patients with AIDS and Related Disorders.

Clinical Pharmacokinetics of Suramin in Patients With HTLV-III/LAV Infection.

Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone<sup>*</sup>.

Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium.

Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver.

The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.

Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.

Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation.

Cytosine arabinoside cerebrospinal fluid kinetics.

Inhibition of first-pass metabolism in cancer chemotherapy: Interaction of 6-mercaptopurine and allopurinol.

Test dose for predicting high-dose methotrexate infusions.

Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.

Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routes.